Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
| Name (Synonyms) | Correlation | |
|---|---|---|
| drug4048 | Traditional Chinese Medicine Prescription Wiki | 1.00 |
| drug4650 | placebo Wiki | 0.26 |
| Name (Synonyms) | Correlation | |
|---|---|---|
| D045169 | Severe Acute Respiratory Syndrome NIH | 0.04 |
| D018352 | Coronavirus Infections NIH | 0.04 |
| Name (Synonyms) | Correlation |
|---|
Navigate: Correlations HPO
There is one clinical trial.
Virgin Coconut Oil (VCO) contains multiple compounds which have antibacterial, antiviral, and immunomodulatory properties. The role of VCO as an antivirus to treat COVID-19 requires further studies. A previous study has investigated the used of 30 ml of VCO to healthy volunteers for a month and reported no side effect. Here the investigators conduct a pilot trial to investigate the effect of VCO towards the clinical outcomes of COVID-19 patients in Indonesia.
Description: Clinical improvement determined by the World Health Organization (WHO) in ordinal scale (0-8)
Measure: Ordinal scale for measuring clinical improvement by the World Health Organization (WHO) Time: 14 daysDescription: Duration of symptoms (fever, respiratory rate or shortness of breath, and cough) that is calculated according to the start of VCO or placebo administration until symptoms disappear, obtained based on anamnesis and physical examination
Measure: Clinical symptoms improvement, determined with interview and examination Time: 14 daysDescription: Probable side effects of the virgin coconut oil, i.e. headache, stomachache, muscle pain, measured in Visual Analog Scale (0-10)
Measure: Pain as side effects of the drugs, measured by Visual Analog Scale Time: 14 daysDescription: Probable side effects of the virgin coconut oil, i.e. allergic reaction severity, categorized in mild, moderate, or severe reaction.
Measure: Allergic reaction severity in mild, moderate, or severe Time: 14 daysDescription: leucocyte count, measured in 1000/micro liter
Measure: Laboratory outcome of leucocyte count Time: 14 daysDescription: lymphocyte count, measured in percentage
Measure: Laboratory outcome of lymphocyte count Time: 14 daysDescription: Neutrophil count, measured in percentage
Measure: Laboratory outcome of neutrophil count Time: 14 daysDescription: neutrophil to lymphocyte ratio, in scale
Measure: Laboratory outcome of neutrophil to lymphocyte ratio, in scale Time: 14 daysDescription: D-dimer measured in microgram/Liter
Measure: Laboratory outcome of D-dimer Time: 14 daysDescription: TNF-alpha, measured in pg/ml
Measure: Laboratory outcome of TNF-alpha Time: 14 daysDescription: CRP value measured in qualitative value
Measure: Laboratory outcome of CRP value Time: 14 daysDescription: IL-6 value measured in pg/ml
Measure: Laboratory outcome of IL-6 Time: 14 daysDescription: Ferritin value measured in mcg/liter
Measure: Laboratory outcome of ferritin Time: 14 daysDescription: procalcitonin in microgram/liter
Measure: Laboratory outcome of procalcitonin Time: 14 daysDescription: chest radiology outcome, measured as improvement of infiltrate based on expert assessment in day 1 and 14
Measure: chest radiology outcome, measured as improvement of infiltrate based on expert assessment Time: 14 daysAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports